Latest Insurance News

QBE Insurance Group reports sustained gross written premium growth of 6% for FY25 and announces a significant A$450 million on-market share buyback, reinforcing confidence in its financial outlook and capital management strategy.

Tower Limited has reported a record underlying profit for FY25, driven by improved claims ratios, customer growth, and strategic initiatives including expanded risk-based pricing. The insurer declared increased dividends and outlined a positive growth outlook for FY26.

Proteomics International secures a key Medicare reimbursement rate for its PromarkerD test, a predictive diagnostic for diabetic kidney disease, marking a critical step in its US commercial rollout.

Monadelphous has reported a record-breaking year with $2.3 billion in new contracts and a strong financial performance, underpinned by strategic acquisitions and growth in energy transition sectors.

Race Oncology Limited has secured shareholder approval for a replacement Constitution at its 2025 Annual General Meeting, updating its corporate governance framework to align with current regulatory standards.

Verbrec Limited reported record FY2025 financial results with its highest gross and adjusted EBITDA margins in years, alongside strategic moves including the acquisition of Alliance Automation and divestment of its Competency Training business.

Lumos Diagnostics has achieved a major milestone by securing 100% Medicare reimbursement recognition for its FebriDx test across all seven US Medicare Administrative Contractors, paving the way for broader adoption in the American healthcare system.

Emyria Limited is fast-tracking its national rollout of Empax mental health clinics, backed by a strong $8 million institutional placement and new dual-payer funding pathways.

Turners Automotive Group has posted a resilient and record first-half result for FY26, with net profit before tax up 13% despite ongoing economic challenges. The company’s diversified model and strategic capital moves underpin its confident outlook.

Turners Automotive Group has delivered a record first-half profit for FY26, driven by strong growth in its Finance and Insurance divisions despite ongoing supply constraints in the used vehicle market. The company also raised its interim dividend, signalling confidence in its diversified business model and capital management strategy.

Whitefield Industrials reported a 4% decline in net profit for the half-year to September 2025 but maintained a strong fully franked dividend and delivered portfolio returns above its benchmark.

BCAL Diagnostics is preparing to launch its Avantect® pancreatic and ovarian cancer blood tests in Australia by January 2026, following key regulatory approvals and promising clinical data. The company also broadens the reach of its BREASTESTplus™ breast cancer test, targeting a larger segment of women with dense breast tissue.